Journals / Acta Medica Alanya / 2026 / Cilt: 10 Sayı: 3

Effects of Borago officinalis Extract and 3,4-Dimethoxycinnamic Acid on BDNF/CREB Signaling and Neurotransmitters in a Scopolamine-Induced Alzheimer’s Model

Borago officinalis Ekstresi ve 3,4-Dimetoksisinnamik Asidin Skopolamin ile İndüklenen Alzheimer Modelinde BDNF/CREB Sinyal Yolakları ve Nörotransmitterler Üzerine Etkileri

Ares Alizade(VAN YÜZÜNCÜ YIL ÜNİVERSİTESİ)
Nur Akman(van yüzüncü yıl üniversitesi sağlık bilimleri fakültesi)0000-0003-4963-068X
Pages
272–281
Publication Date
2026-10-20
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The superior efficacy of 3,4-DMCA suggests that hydroxycinnamic acid derivatives may represent key active components responsible for the neuroprotective effects of BO, highlighting their potential as multi-target therapeutic candidates for Alzheimer’s disease

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study aimed to comparatively evaluate the neuroprotective effects of Borago officinalis (BO) extract and 3,4-dimethoxycinnamic acid (3,4-DMCA) on BDNF/CREB signaling pathways and neurotransmitter systems in a scopolamine (SCP)-induced in vitro Alzheimer’s disease model.
📊
Key Findings & Data:Methods: HT22 hippocampal and SH-SY5Y prefrontal neuronal cell lines were used.
💡
Conclusion & Impact:The superior efficacy of 3,4-DMCA suggests that hydroxycinnamic acid derivatives may represent key active components responsible for the neuroprotective effects of BO, highlighting their potential as multi-target therapeutic candidates for Alzheimer’s disease
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Alzheimer hastalığı · Borago officinalis · BDNF

Abstract

Aim: This study aimed to comparatively evaluate the neuroprotective effects of Borago officinalis (BO) extract and 3,4-dimethoxycinnamic acid (3,4-DMCA) on BDNF/CREB signaling pathways and neurotransmitter systems in a scopolamine (SCP)-induced in vitro Alzheimer’s disease model. Methods: HT22 hippocampal and SH-SY5Y prefrontal neuronal cell lines were used. Cells were divided into control, sham, SCP (2 mM), SCP+BO (15 μg/mL), SCP+3,4- DMCA (25 μM), and SCP+galantamine (1 μM) groups. Following treatment, BDNF, CREB, glutamate, acetylcholinesterase (AChE), acetylcholine (ACh), and norepinephrine (NE) levels were measured using ELISA. Results: SCP exposure significantly decreased BDNF, CREB, ACh, and NE levels and increased glutamate and AChE levels in both cell lines (p 0.05). Notably, 3,4-DMCA demonstrated more pronounced effects than BO on selected parameters, with significantly lower AChE levels and higher ACh levels in both cell lines (p<0.05). ’Conclusion: BO extract and especially 3,4-DMCA attenuate SCP-induced neuroplasticity impairment and neurotransmitter imbalance. The superior efficacy of 3,4-DMCA suggests that hydroxycinnamic acid derivatives may represent key active components responsible for the neuroprotective effects of BO, highlighting their potential as multi-target therapeutic candidates for Alzheimer’s disease

Özet

Amaç: Bu çalışmada, Borago officinalis (BO) ekstresi ve 3,4-dimetoksisinnamik asidin (3,4-DMCA), skopolamin (SCP) ile indüklenen in vitro Alzheimer modeli kapsamında BDNF/CREB sinyal yolakları ve nörotransmitter sistemler üzerindeki nöroprotektif etkilerinin karşılaştırmalı olarak değerlendirilmesi amaçlanmıştır. Yöntem: Çalışmada HT22 hipokampal ve SH-SY5Y prefrontal nöronal hücre hatları kullanılmıştır. Hücreler kontrol, sham, SCP (2 mM), SCP+BO (15 μg/mL), SCP+3,4- DMCA (25 μM) ve SCP+galantamin (1 μM) gruplarına ayrılmıştır. Uygulama sonrası BDNF, CREB, glutamat, asetilkolinesteraz (AChE), asetilkolin (ACh) ve norepinefrin (NE) düzeyleri ELISA yöntemi ile belirlenmiştir. Bulgular: SCP uygulaması, her iki hücre hattında BDNF, CREB, ACh ve NE düzeylerinde anlamlı azalmaya, glutamat ve AChE düzeylerinde ise anlamlı artışa neden olmuştur (p 0,05). Özellikle 3,4-DMCA, bazı parametrelerde BO’ya kıyasla daha belirgin etkiler göstermiş; her iki hücre hattında da BO grubuna kıyasla AChE düzeyleri anlamlı düzeyde daha düşük, ACh düzeyleri ise anlamlı düzeyde daha yüksek bulunmuştur (p<0,05). Sonuç: BO ekstresi ve özellikle 3,4-DMCA, SCP ile indüklenen nöroplastisite bozukluğu ve nörotransmitter dengesizliğini azaltmaktadır. 3,4-DMCA’nın daha güçlü etkileri, hidroksisinnamik asit türevlerinin BO’nun nöroprotektif etkilerinden sorumlu temel aktif bileşenler olabileceğini göstermekte ve bu bileşiklerin Alzheimer hastalığına yönelik çok hedefli terapötik ajanlar olarak potansiyelini ortaya koymaktadır.

🔖

Cite This Article

Alizade, A., Akman, N. (2026). Effects of Borago officinalis Extract and 3,4-Dimethoxycinnamic Acid on BDNF/CREB Signaling and Neurotransmitters in a Scopolamine-Induced Alzheimer’s Model. Acta Medica Alanya, Cilt: 10 Sayı: 3, 272–281. https://doi.org/10.30565/medalanya.1949567

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (51)

  1. Baek H, Park M, Lee HJ. Nobiletin ameliorates Alzheimer’s disease pathology by reducing oxidative stress and neuroinflammation through the AMPK/SIRT1/PGC-1α and PI3K/Akt–CREB–BDNF pathways in 5XFAD mice. Biomedicines. 2026;14(3):561. doi:10.3390/biomedicines14030561.
  2. Xu X, Zhao Y, Ma H, Hu Y, Yu L, Su Y, et al. Mechanism of Atractylodis Rhizoma in improving cognitive dysfunction in Alzheimer’s disease by regulating the cAMP/CREB/BDNF pathway. Int Immunopharmacol. 2026;168(Pt 2):115923. doi:10.1016/j.intimp.2025.115923.
  3. Hein ZM, Karikalan B, Gopalakrishna PK, Dhevi K, Alkatiri A, Hussan F, et al. Toward a unified framework in molecular neurobiology of Alzheimer’s disease: revisiting the pathophysiological hypotheses. Mol Neurobiol. 2026;63(1):282. doi:10.1007/s12035-025-05602-0.
  4. Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, et al. An expanded narrative review of neurotransmitters on Alzheimer’s disease: the role of therapeutic interventions on neurotransmission. Mol Neurobiol. 2025;62(2):1631-74. doi:10.1007/s12035-024-04333-y.
  5. Alqahtani SM, Al-Kuraishy HM, Al Gareeb AI, Albuhadily AK, Alexiou A, Papadakis M, et al. Unlocking Alzheimer’s disease: the role of BDNF signaling in neuropathology and treatment. Neuromolecular Med. 2025;27(1):36. doi:10.1007/s12017-025-08857-x.
  6. Akman N, Kömüroğlu AU, Çibuk S, Altındağ F, Yılmaz O, Ateşşahin A. Effects of infliximab in a propionic acid-induced experimental autism rat model. Biomedicines. 2026;14(4):940. doi:10.3390/biomedicines14040940.
  7. Zota I, Chanoumidou K, Gravanis A, Charalampopoulos I. Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer’s disease. Front Cell Neurosci. 2024;18:1422130. doi:10.3389/fncel.2024.1422130.
  8. Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK. The role of CREB and BDNF in the neurobiology and treatment of Alzheimer’s disease. Life Sci. 2020;257:118020. doi:10.1016/j.lfs.2020.118020.
  9. Ansari AZ, Park GS, Park SJ, Goh AR, Je KH. Sobrerol improves memory impairment in the scopolamine-induced amnesia mouse model. Int J Mol Sci. 2025;26(10):4613. doi:10.3390/ijms26104613.
  10. Ahmad W, Choe K, Ahmad R, Park TJ, Kim MO. Ambroxol confers neuroprotection against scopolamine-induced Alzheimer’s-like pathology by modulating oxidative stress, neuroinflammation, and cognitive deficits via Nrf-2/JNK/GSK-3β signaling pathways. Front Aging Neurosci. 2025;17:1607289. doi:10.3389/fnagi.2025.1607289.
  11. Sen Metin F, Aksoz E. Dose-dependent effects of vildagliptin (DPP-4 inhibitor) in a scopolamine-induced memory impairment model in rats. Life Sci. 2026;389:124245. doi:10.1016/j.lfs.2026.124245.
  12. Kim SH, Kim SJ, Ko EJ, Lee HR, Hong SM, Ryu SH, et al. Standardized Hericium erinaceus extract powder improves scopolamine-induced cognitive deficits via BDNF-mediated neuroplasticity. Sci Pharm. 2026;94(1):12. doi:10.3390/scipharm94010012.
  13. Akman N, Kömüroğlu AU. Effect of ciprofloxacin on some oxidative stress parameters and TNF-α, IL-6 and BDNF in diabetic rats with urinary tract infection induced by Escherichia coli. Indian J Pharm Educ Res. 2026;60(2):566-74. doi:10.5530/ijper.20266403.
  14. Moliner C, Cásedas G, Barros L, Finimundy TC, Gómez-Rincón C, López V. Neuroprotective profile of edible flowers of borage (Borago officinalis L.) in two different models: Caenorhabditis elegans and Neuro-2a cells. Antioxidants (Basel). 2022;11(7):1244. doi:10.3390/antiox11071244.
  15. Zadernowski R, Naczk M, Nowak-Polakowska H. Phenolic acids of borage (Borago officinalis L.) and evening primrose (Oenothera biennis L.). J Am Oil Chem Soc. 2002;79(4):335-8. doi:10.1007/s11746-002-0484-8.
  16. Michalak M, Zagórska-Dziok M, Klimek-Szczykutowicz M, Szopa A. Phenolic profile and comparison of the antioxidant, anti-ageing, anti-inflammatory, and protective activities of Borago officinalis extracts on skin cells. Molecules. 2023;28(2):868. doi:10.3390/molecules28020868.
  17. Borowy A, Kapłan M. Chemical composition and antioxidant activity of borage (Borago officinalis L.) seeds. Acta Sci Pol Hortorum Cultus. 2020;19(6):79-90. doi:10.24326/asphc.2020.6.7.
  18. Xue Z, Shui M, Lin X, Sun Y, Liu J, Wei C, et al. Role of BDNF/proBDNF imbalance in postoperative cognitive dysfunction by modulating synaptic plasticity in aged mice. Front Aging Neurosci. 2022;14:780972. doi:10.3389/fnagi.2022.780972.
  19. Moallem SA, Hosseinzadeh H, Ghoncheh F. Evaluation of antidepressant effects of aerial parts of Echium vulgare on mice. Iran J Basic Med Sci. 2007;10(3):189-96. doi:10.22038/ijbms.2007.5294.
  20. Puangmalai N, Thangnipon W, Soi-Ampornkul R, Govitrapong P. Neuroprotection of N-benzylcinnamide on scopolamine-induced cholinergic dysfunction in SH-SY5Y cells. Neural Regen Res. 2017;12(12):2089-97. doi:10.4103/1673-5374.221166.
  21. Ruwizhi N, Aderibigbe BA. Cinnamic acid derivatives and their biological efficacy. Int J Mol Sci. 2020;21(16):5712. doi:10.3390/ijms21165712.
  22. Sie YY, Chen LC, Li CJ, Yuan YH, Hsiao SH, Lee MH, et al. Inhibition of acetylcholinesterase and amyloid-β aggregation by piceatannol and analogs: assessing in vitro and in vivo impact on a murine model of scopolamine-induced memory impairment. Antioxidants (Basel). 2023;12(7):1362. doi:10.3390/antiox12071362.
  23. Ghafary S, Najafi Z, Mohammadi-Khanaposhtani M, Nadri H, Edraki N, Ayashi N, et al. Novel cinnamic acid–tryptamine hybrids as potent butyrylcholinesterase inhibitors: synthesis, biological evaluation, and docking study. Arch Pharm (Weinheim). 2018;351(10):1800115. doi:10.1002/ardp.201800115.
  24. Guo S, Zhen Y, Zhu Z, Zhou G, Zheng X. Cinnamic acid rescues behavioral deficits in a mouse model of traumatic brain injury by targeting miR-455-3p/HDAC2. Life Sci. 2019;235:116819. doi:10.1016/j.lfs.2019.116819.
  25. Alacabey NA, Coşkun D, Çeribaşi S, Ateşşahin A. Effects of boron on learning and behavioral disorders in rat autism model induced by intracerebroventricular propionic acid. Biol Trace Elem Res. 2025;203(6):3258-71. doi:10.1007/s12011-024-04417-9.
  26. Fan X, Wang H, Lv X, Wang Q, Yu B, Li X, et al. The pCREB/BDNF pathway in the hippocampus is involved in the therapeutic effect of selective 5-HT reuptake inhibitors in adult male rats exposed to blast traumatic brain injury. Brain Sci. 2025;15(3):236. doi:10.3390/brainsci15030236.
  27. Pariyar R, Yoon CS, Svay T, Kim DS, Cho HK, Kim SY, et al. Vitis labruscana leaf extract ameliorates scopolamine-induced impairments with activation of Akt, ERK and CREB in mice. Phytomedicine. 2017;36:8-17. doi:10.1016/j.phymed.2017.09.008.
  28. Lee SB, Yang SY, Thao NP, Seo DG, Kim S, Ma CT, et al. Protective effects of compounds from Cimicifuga dahurica against amyloid beta production in vitro and scopolamine-induced memory impairment in vivo. J Nat Prod. 2020;83(2):223-30. doi:10.1021/acs.jnatprod.9b00543.
  29. Connor B, Young D, Yan Q, Faull RLM, Synek B, Dragunow M. Brain-derived neurotrophic factor is reduced in Alzheimer’s disease. Brain Res Mol Brain Res. 1997;49(1-2):71-81. doi:10.1016/S0169-328X(97)00125-3.
  30. Lee JS, Kim HG, Lee HW, Han JM, Lee SK, Kim DW, et al. Hippocampal memory-enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model. Sci Rep. 2015;5:9651. doi:10.1038/srep09651.
  31. Hong SM, Soe KH, Lee TH, Kim IS, Lee YM, Lim BO. Cognitive improving effects by highbush blueberry (Vaccinium corymbosum L.) vinegar on scopolamine-induced amnesia mice model. J Agric Food Chem. 2018;66(1):99-107. doi:10.1021/acs.jafc.7b03965.
  32. Xue W, Hu JF, Yuan YH, Sun JD, Li BY, Zhang DM, et al. Polygalasaponin XXXII from Polygala tenuifolia root improves hippocampal-dependent learning and memory. Acta Pharmacol Sin. 2009;30(9):1211-9. doi:10.1038/aps.2009.112.
  33. Patil P, Jaiswal S, Prabhu A. Exploring the potential of cinnamic acid analogues in Alzheimer’s disease. Daru. 2026;34(1):16. doi:10.1007/s40199-026-00593-2.
  34. Hwang SA, Kim CD, Lee WS. Caffeic acid phenethyl ester protects against photothrombotic cortical ischemic injury in mice. Korean J Physiol Pharmacol. 2018;22(1):101-10. doi:10.4196/kjpp.2018.22.1.101.
  35. Cheng CY, Tang NY, Kao ST, Hsieh CL. Ferulic acid administered at various time points protects against cerebral infarction by activating p38 MAPK/p90RSK/CREB/Bcl-2 anti-apoptotic signaling in the subacute phase of cerebral ischemia-reperfusion injury in rats. PLoS One. 2016;11(5):e0155748. doi:10.1371/journal.pone.0155748.
  36. Cheng Q, Yakel JL. Presynaptic α7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation. J Neurosci. 2014;34(1):124-33. doi:10.1523/JNEUROSCI.2973-13.2014.
  37. Silva AJ, Kogan JH, Frankland PW, Kida S. CREB and memory. Annu Rev Neurosci. 1998;21:127-48. doi:10.1146/annurev.neuro.21.1.127.
  38. Kandel ER. The molecular biology of memory storage: a dialogue between genes and synapses. Science. 2001;294(5544):1030-8. doi:10.1126/science.1067020.
  39. Lewerenz J, Maher P. Chronic glutamate toxicity in neurodegenerative diseases—what is the evidence? Front Neurosci. 2015;9:469. doi:10.3389/fnins.2015.00469.
  40. Cunha C, Brambilla R, Thomas KL. A simple role for BDNF in learning and memory? Front Mol Neurosci. 2010;3:1. doi:10.3389/neuro.02.001.2010.
  41. Caldeira MV, Melo CV, Pereira DB, Carvalho RF, Carvalho AL, Duarte CB. BDNF regulates the expression and traffic of NMDA receptors in cultured hippocampal neurons. Mol Cell Neurosci. 2007;35(2):208-19. doi:10.1016/j.mcn.2007.02.019.
  42. Slama M, Slougui N, Benaissa A, Nekkaa A, Sellam F, Canabady-Rochelle L. Borago officinalis L.: a review on extraction, phytochemical, and pharmacological activities. Chem Biodivers. 2024;21(5):e202301822. doi:10.1002/cbdv.202301822.
  43. Cunha FVM, Gomes BDS, Neto BDS, Ferreira AR, de Sousa DP, Martins MDCDC, et al. Ferulic acid ethyl ester diminished complete Freund’s adjuvant-induced incapacitation through antioxidant and anti-inflammatory activity. Naunyn Schmiedebergs Arch Pharmacol. 2016;389(1):117-30. doi:10.1007/s00210-015-1180-8.
  44. Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain. 2018;141(7):1917-33. doi:10.1093/brain/awy132.
  45. Marucci G, Buccioni M, Dal Ben D, Lambertucci C, Volpini R, Amenta F. Efficacy of acetylcholinesterase inhibitors in Alzheimer’s disease. Neuropharmacology. 2021;190:108352. doi:10.1016/j.neuropharm.2020.108352.
  46. Zhang K, Han Y, Zhang P, Zheng Y, Cheng A. Comparison of fluorescence biosensors and whole-cell patch clamp recording in detecting ACh, NE, and 5-HT. Front Cell Neurosci. 2023;17:1166480. doi:10.3389/fncel.2023.1166480.
  47. Kumar A, Singh A, Ekavali. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195-203. doi:10.1016/j.pharep.2014.09.004.
  48. Wang S, Su G, Zhang X, Song G, Zhang L, Zheng L, et al. Characterization and exploration of potential neuroprotective peptides in walnut (Juglans regia) protein hydrolysate against cholinergic system damage and oxidative stress in scopolamine-induced cognitive and memory impairment mice and zebrafish. J Agric Food Chem. 2021;69(9):2773-83. doi:10.1021/acs.jafc.0c07798.
  49. Liu YH, Lee CJ, Chen LC, Lee TL, Hsieh YY, Han CH, et al. Acetylcholinesterase inhibitory activity and neuroprotection in vitro, molecular docking, and improved learning and memory functions of demethylcurcumin in scopolamine-induced amnesia ICR mice. Food Funct. 2020;11(3):2328-38. doi:10.1039/C9FO02339A.
  50. Chen M, Russo-Neustadt A. Norepinephrine induces BDNF and activates CREB and discriminates among protein kinase C isoforms in cultured embryonic hippocampal neurons. Neurosci Med. 2017;8:53-67. doi:10.4236/nm.2017.84008.
  51. Balapattabi K, Patil CN, Deng G, Sigmund CD, Grobe JL. CREB and ERK activation by leptin and angiotensin in the GT1-7 cell model by capillary electrophoresis-based Western blotting. FASEB J. 2020;34(S1):1. doi:10.1096/fasebj.2020.34.s1.02546.